Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality

Clinical Infectious Diseases

Volumn 23, Issue 6, 1996, Pages 1234-1239

  Edmond, Michael B ^a   Ober, Janis F ^b   Dawson, Jeffrey D ^b   Weinbaum, David L ^b   Wenzel, Richard P ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROCOCCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RATE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SEPSIS; SEPTIC SHOCK; SURGICAL MORTALITY;

EID: 0030459510     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.6.1234     Document Type: Article

References (12)

1. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;91(suppl 3B):86S-9S.
2. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993; 6: 428-42.
3. Garrison RN, Fry DE, Berberich S, Polk HC Jr. Enterococcal bacteremia: clinical implications and determinants of death. Ann Surg 1982; 196: 43-7.
4. Klimek JJ, Ajemian E, Gracewski J, et al. Enterococcal infections in a large community hospital, with emphasis on bacteremia. Am J Infect Control 1980; 8:58-61.
5. Dougherty SH, Flohr AB, Simmons RL. "Breakthrough" enterococcal septicemia in surgical patients: 19 cases and a review of the literature. Arch Surg 1983; 118:232-8.
6. Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 1988; 67: 248-69.
7. Holm SE. Gram-positive microorganisms in sepsis. Scand J Infect Dis Suppl 1982; 31:68-77.
8. Landry SL, Kaiser DL, Wenzel RP. Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study. Am J Infect Control 1989; 17:323-9.
9. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993; 42:597-9.
10. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enlerococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20:1126-33.
11. Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994; 38:1363-7.
12. Vasquez A, Lutfey M, Ticci L, Serrell F, Kreiswirth B, Simberkoff M. Clinical, microbiologic, and epidemiologic evaluation of vancomycin-resistant Enterococcus faecium [abstract no 852]. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1993:275.